Opportunity ID: 241773

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: PAR-13-325
Funding Opportunity Title:: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.173 — Research Related to Deafness and Communication Disorders
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Sep 04, 2013
Last Updated Date::
Original Closing Date for Applications:: Sep 07, 2016
Current Closing Date for Applications:: Sep 07, 2016
Archive Date:: Oct 08, 2016
Estimated Total Program Funding::
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: City or township governments
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: This Funding Opportunity Announcement (FOA) encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Package No: 2

Assistance Listings:
Competition ID: FORMS-D
Competition Title: Use for due dates on or after May 25, 2016
Opportunity Package ID: PKG00222110
Opening Date: Apr 17, 2016
Closing Date: Sep 07, 2016
Agency Contact Information:: eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/
Who Can Apply:: Organization Applicants
mendatory_forms SF424 (R & R) [V2.0]
PHS 398 Cover Page Supplement [V3.0]
Research And Related Other Project Information [V1.3]
Project/Performance Site Location(s) [V2.0]
Research and Related Senior/Key Person Profile (Expanded) [V2.0]
PHS 398 Research Plan [V3.0]
optional_forms Research & Related Budget [V1.3]
R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.3]
PHS 398 Modular Budget [V1.2]
PHS Inclusion Enrollment Report [V1.0]
PHS Assignment Request Form [V1.0]